Abstract
Over the last 50 years, newly described species of Emmonsia-like fungi have been implicated globally as sources of systemic human mycosis (emmonsiosis). Their ability to convert into yeast-like cells capable of replication and extra-pulmonary dissemination differentiates them from classical Emmonsia species. Immunocompromised patients are at highest risk of emmonsiosis and exhibit high mortality rates. In order to investigate the molecular basis for pathogenicity of the newly described Emmonsia species, genomic sequencing and comparative genomic analyses of Emmonsia sp. 5z489, which was isolated from a non-deliberately immunosuppressed diabetic patient in China and represents a novel seventh isolate of Emmonsia-like fungi, was performed. The genome size of 5z489 was 35.5 Mbp in length, which is ~5 Mbp larger than other Emmonsia strains. Further, 9,188 protein genes were predicted in the 5z489 genome and 16% of the assembly was identified as repetitive elements, which is the largest abundance in Emmonsia species. Phylogenetic analyses based on whole genome data classified 5z489 and CAC-2015a, another novel isolate, as members of the genus Emmonsia. Our analyses showed that divergences among Emmonsia occurred much earlier than other genera within the family Ajellomycetaceae, suggesting relatively distant evolutionary relationships among the genus. Through comparisons of Emmonsia species, we discovered significant pathogenicity characteristics within the genus as well as putative virulence factors that may play a role in the infection and pathogenicity of the novel Emmonsia strains. Moreover, our analyses revealed a novel distribution mode of DNA methylation patterns across the genome of 5z489, with >50% of methylated bases located in intergenic regions. These methylation patterns differ considerably from other reported fungi, where most methylation occurs in repetitive loci. It is unclear if this difference is related to physiological adaptations of new Emmonsia, but this question warrants further investigation. Overall, our analyses provide a framework from which to further study the evolutionary dynamics of Emmonsia strains and identity the underlying molecular mechanisms that determine the infectious and pathogenic potency of these fungal pathogens, and also provide insight into potential targets for therapeutic intervention of emmonsiosis and further research.
Introduction
Historically, fungi in the genus Emmonsia were primarily associated with adiaspiromycosis, a rare pulmonary disease in rodents. However, the emergence of "Emmonsia-like" species over the past five decades has introduced a significant threat to human health. Unlike classical species, these emerging pathogens can transform into yeast-like cells that disseminate from the lungs to systemic sites, resulting in high mortality rates, particularly among immunocompromised individuals such as those with HIV or diabetes. This study focuses on Emmonsia sp. 5z489, a novel isolate from a diabetic patient in China, to elucidate the genomic features and molecular mechanisms underlying the increased virulence of these emerging pathogens.
Methods
Researchers utilized a hybrid sequencing strategy to generate a high-quality genome assembly for Emmonsia sp. 5z489. This approach combined Pacific Biosciences (PacBio) RS II long-read sequencing, which is effective for resolving complex repetitive regions, with Illumina MiSeq short-read sequencing for high-accuracy error correction.
The resulting genome was analyzed using comparative genomics (OrthoMCL) against three other Emmonsia species: E. crescens UAMH 3008, E. parva UAMH 139, and Emmonsia sp. CAC-2015a. Pathogenicity profiling was conducted using the Pathogen-Host Interaction (PHI) database and the Database of Fungal Virulence Factors (DFVF). Additionally, PacBio technology enabled the mapping of the epigenome, specifically DNA methylation patterns (m4C and m6A).
Results and Discussion
Evolutionary Relationships and Taxonomy
Phylogenetic analysis based on whole-genome data confirmed that Emmonsia sp. 5z489 and CAC-2015a are members of the genus Emmonsia. However, the analysis also revealed that the genus diverged much earlier than other genera within the family Ajellomycetaceae. Notably, E. parva appeared more closely related to Blastomyces than to other Emmonsia species, suggesting a need for taxonomic re-evaluation of the family.
Genomic Complexity and Comparative Analysis
The genome of Emmonsia sp. 5z489 is approximately 35.5 Mbp, which is significantly larger than its relatives. It contains 9,188 predicted protein-coding genes and a high proportion of repetitive elements (16.4%). Comparative analysis identified shared and unique gene families among the four studied Emmonsia species, highlighting the genomic diversity within the genus.
Putative Virulence Factors and Epigenetic Patterns
The study identified several protein families enriched in the pathogenic strains, including pectate lyases and protein kinases (CK1), which may facilitate tissue invasion and the transition to the yeast phase. Interestingly, the low abundance of aminoglycoside phosphotransferase (APH) proteins suggests potential sensitivity to certain aminoglycoside antibiotics.
A striking finding was the unique DNA methylation pattern in 5z489. Unlike most fungi, where methylation silences repetitive regions, over 50% of methylated bases in 5z489 were located in intergenic regions. This suggests a novel mode of gene regulation that may contribute to host adaptation.
Conclusion
This genomic map of Emmonsia sp. 5z489 provides a critical foundation for understanding the pathogenicity of emerging Emmonsia species. While the identified virulence factors and epigenetic signatures offer promising leads, experimental validation through gene knockout studies is necessary to confirm their functional roles. These findings highlight potential targets for therapeutic intervention and underscore the need for continued research into the evolutionary dynamics of these dangerous fungal pathogens.
Summary updated